Diferencia entre revisiones de «Antiarrhythmics»
Sin resumen de edición |
|||
| Línea 45: | Línea 45: | ||
*Wide-complex tachycardia of unknown type (in pts w/ preserved LV function) | *Wide-complex tachycardia of unknown type (in pts w/ preserved LV function) | ||
*Stable V-tach | *Stable V-tach | ||
===Mechanism of Action=== | ===Mechanism of Action=== | ||
*Class Ia | *Class Ia | ||
| Línea 59: | Línea 59: | ||
*Onset of action = 5-10min | *Onset of action = 5-10min | ||
=== | ==Esmolol== | ||
===Adult Dosing=== | |||
*Loading dose = 500mcg/kg bolus over 1min | |||
**Follow this w/ infusion at 50mcg/kg/min for 4min | |||
***If no response give another 500 bolus, incr infusion to 100 | |||
***If no response give another 500 bolus, incr infusion to 200 | |||
===Contraindications=== | |||
*Cardiogenic shock | |||
*2nd or 3rd AV block | |||
===Indications=== | |||
*Supraventricular arrhythmias | |||
===Mechanism of Action=== | |||
*Class II - Short-acting Beta1 blocker | |||
===Adverse Drug Rxns=== | |||
*Hypotension | |||
*Bronchospasm | |||
===Kinetics=== | |||
Onset of action = 1-4min | |||
Duration of action = <30min | |||
==Labetalol== | |||
===Adult Dosing=== | |||
*Bolus dosing | |||
**20mg IV followed by 40-80mg q10min up to total of 300mg | |||
*Infusion dosing | |||
**0.5-2mg/min | |||
===Indications=== | |||
*HTN in setting of myocardial ischemia | |||
*HTN in setting of neurologic injury | |||
*HTN in setting of preeclampsia/eclampsia | |||
===Mechanism of Action=== | |||
*Class II - Nonselective beta blocker | |||
*Alpha1 blocker | |||
===Adverse Drug Rxns=== | |||
*Orthostatic hypotension | |||
===Kinetics=== | |||
*Onset of action = 2-5min (IV) | |||
*Duration of action = 2-4hr (IV) | |||
==Sotalol== | |||
===Adult Dosing=== | |||
*80mg PO BID | |||
===Indications=== | |||
*Suppression of ventricular arrhythmias refractory to other meds | |||
*Suppression of SVT, a-fib | |||
===Mechanism of Action=== | |||
*Class II - Nonselective beta-blocker | |||
*Class III effects (prolongs repol and refractoriness) | |||
===Adverse Drug Rxns=== | |||
*Hypotension, bradycardia | |||
*Proarrhythmia (esp in pts w/ hypokalemia) | |||
===Kinetics=== | |||
*Onset of action = 2-3hr | |||
*Duration of action = 24hr | |||
==Amiodarone== | |||
===Adult Dosing=== | |||
*V-fib/pulseless V-tach | |||
**Loading dose = 300mg IV bolus followed by 150mg bolus prn | |||
*Stable V-tach or SVT | |||
**Loading dose = 150mg IV in 100mL D5W over 10min | |||
***Follow by infusion of 1mg/min x 6hr; 0.5mg/min thereafter | |||
===Contraindications=== | |||
Iodine or shellfish allergy | |||
===Indications=== | |||
*Ventricular and supraventricular arrhythmias | |||
*1st line for pulseless V-tach/V-fib | |||
*Used for atrial arrhythmias in pts w/ decr EF | |||
===Mechanism of Action=== | |||
*Class III - Inhibits potassium channels | |||
**Impairs SA and AV node conduction | |||
**Decreases automaticity | |||
**Prolongs refractory period in accessory pathways | |||
*Also has class I & II properties | |||
===Adverse Drug Rxns=== | |||
*Bradycardia, hypotension | |||
==Ibutilide== | |||
===Adult Dosing=== | |||
*Loading dose = 1mg IV in 50mL D5W over 10min (wt>60kg) | |||
*Loading dose = 0.01mg/kg IV in 50mL D5W over 10min (wt<60kg) | |||
*Dose may be repeated 10min after completion of 1st dose | |||
===Contraindications=== | |||
===Indications=== | |||
*Rapid conversion of recent-onset A-fib/flutter to NSR | |||
===Mechanism of Action=== | |||
*Class III - Prolongs AP and refractory period | |||
===Adverse Drug Rxns=== | |||
*QT prolongation, V-tach, torsades | |||
*Observe for 4hr after infusion | |||
===Kinetics=== | |||
*Onset of action = 20-30min | |||
*Duration of action = 24hr | |||
==Diltiazem== | |||
===Adult Dosing=== | |||
*Loading dose = 0.25mg/kg (max=20mg) IV bolus over 2min | |||
**If ineffective after 15min: 0.35mg/g (max=25mg) over 2min | |||
**If effective: Start infusion at 5-15mg/hr | |||
===Contraindications=== | |||
*Wide-complex tachycardia due to bypass tract | |||
===Indications=== | |||
*Conversion of PSVT to NSR | |||
*Slow RVR in a-fib/flutter | |||
===Mechanism of Action=== | |||
*Class IV - Inhibits Ca influx | |||
**Slows AV nodal conduction | |||
===Adverse Drug Rxns=== | |||
Bradycardia, CHF, AV block, BBB, hypotension | |||
===Kinetics=== | |||
*Onset of action = 2-3min (IV) | |||
*Duration of action = 1-3hr (IV) | |||
==Atropine== | |||
===Adult Dosing=== | |||
*Loading dose = 0.5mg rapid IV bolus q3-5min (max = 0.04 milligram/kg) | |||
*May be given IM, IO, SC | |||
===Indications=== | |||
*Symptomatic sinus or AV nodal bradycardia | |||
===Mechanism of Action=== | |||
*Parasympatholytic | |||
**Increases sinus/AV conduction | |||
===Adverse Drug Rxns=== | |||
*Increased O2 consumption | |||
*If given slowly (or <0.5mg) may lead to paradoxical bradycardia | |||
===Kinetics=== | |||
*Onset of action = 2-4min | |||
*Duration of action = 5hr | |||
==Adenosine== | |||
===Adult Dosing=== | |||
*6mg rapid IV bolus over 1-2s | |||
**If ineffective can try 12mg 2min later | |||
***If still ineffective can try another 12mg | |||
===Contraindications=== | |||
*2nd, 3rd AV block | |||
*Sick sinus syndrome | |||
*Reentrant SVTs not involving AV node are not terminated | |||
*No effect on anterograde WPW | |||
===Indications=== | |||
*Conversion of reentrant PSVT to NSR | |||
===Mechanism of Action=== | |||
*Negative inotropic, dromotropic, chronotropic effects | |||
*Transient AV nodal block | |||
===Adverse Drug Rxns=== | |||
*Bronchoconstriction (responds to bronchodilators) | |||
*Bradyarrhythmia | |||
*Hypotension (if given too slowly) | |||
===Kinetics=== | |||
Onset of action = 20-30s | |||
Duration of action = 60-90s | |||
==Digoxin== | |||
===Adult Dosing=== | ===Adult Dosing=== | ||
*Loading dose = 0.25 mg IV q2hr until effect (max total = 1.5 mg | |||
===Contraindications=== | ===Contraindications=== | ||
*WPW | |||
**Increases conduction velocity in atrial tissue | |||
===Indications=== | |||
*RVR control in a-fib/flutter, PSVT | |||
===Mechanism of Action=== | |||
*Inhibits NaK pump | |||
**Positive inotropy | |||
*Negative chronotropy/dromotropy | |||
**Indirect vagal stimulator | |||
===Adverse Drug Rxns=== | |||
*GI - N/V, diarrhea, abd pain | |||
*CV - Bradycardia, SA/AV block, ventr arrhythmias | |||
===Kinetics=== | |||
Onset of action = 1.5-4hr (IV) | |||
==Isoproterenol== | |||
===Adult Dosing=== | |||
2-10mcg/min IV by continuous infusion | |||
===Indications=== | ===Indications=== | ||
*Refractory torsades | |||
*Refractory symptomatic bradycardia | |||
===Mechanism of Action=== | ===Mechanism of Action=== | ||
*Beta agonist | |||
===Adverse Drug Rxns=== | ===Adverse Drug Rxns=== | ||
*Dramatic increase in O2 demand | |||
*V-tach (use lowest dose possible) | |||
===Kinetics=== | ===Kinetics=== | ||
== | *Onset of action = 1-5min | ||
*Duration of action = 1-2hr | |||
==Magnesium== | |||
===Adult Dosing=== | |||
*Loading dose = 1-2gm in 10mL D5W over 1-2min (cardiac arrest) | |||
*Loading dose = 1-4gm in 50-100 D5W over 20-60min (spontaneous circulation) | |||
===Contraindications=== | |||
===Indications=== | |||
===Mechanism of Action=== | |||
*Increases vasomotor tone | |||
*Prolongs AV conduction; prolongs refractoriness | |||
===Adverse Drug Rxns=== | |||
*Hypotension | |||
===Kinetics=== | |||
*Onset of action = Immediate | |||
* | |||
Revisión del 21:02 9 may 2011
Lidocaine
Adult Dosing
- Loading dose = 1-1.5 mg/kg
- Additional boluses of 0.5-0.75 mg/kg q5-10min up to max of 3mg/kg
- If effective start infusion of 2mg/min
Contraindications
- High SA or AV block
Indications
- Treatment of ventricular arrhythmias and ectopy
- Considered 2nd-line to amiodarone for tx of V-fib and pulseless v-tach
Mechanism of Action
- Class Ib
- Binds to fast Na channels in inactive state thereby inhibiting recovery after repolarization
- Acts preferentially on ischemic tissue
- Elevates V-fib threshold
- Suppresses ventricular ectopy
- Little effect on vascular tone, contractility or cardiac output
Adverse Drug Rxns
- CNS
- Abrupt change in MS, drowsiness, confusion, sz
Kinetics
- Onset of action = 45-90s
- Duration of action = 10-20min
Procainamide
Adult Dosing
- Continuous infusion rate has fewer adverse effects
- 20mg/min for 25-30min
- If effective start cont infusion of 1-4mg/min
- 20mg/min for 25-30min
Contraindications
- Not recommended for V-fib or pulseless V-tach (too long to dose)
- 2nd or 3rd AV block
- Severe glycoside intoxication
- Prolonged QT
- Myasthenia gravis
Indications
- Wide-complex tachycardia of unknown type (in pts w/ preserved LV function)
- Stable V-tach
Mechanism of Action
- Class Ia
- Binds to fast Na channels in inactive state thereby inhibiting recovery after repolarization
- Prolongs action potential and reduces speed of impulse conduction
- Depresses myocardial conduction
- May act as negative inotrope, cause hypotension (peripheral vasodilation)
Adverse Drug Rxns
- Myocardial depression
- Watch for QRS/QT prolongation, V-tach, Vfib, complete AV block, torsades
Kinetics
- Onset of action = 5-10min
Esmolol
Adult Dosing
- Loading dose = 500mcg/kg bolus over 1min
- Follow this w/ infusion at 50mcg/kg/min for 4min
- If no response give another 500 bolus, incr infusion to 100
- If no response give another 500 bolus, incr infusion to 200
- Follow this w/ infusion at 50mcg/kg/min for 4min
Contraindications
- Cardiogenic shock
- 2nd or 3rd AV block
Indications
- Supraventricular arrhythmias
Mechanism of Action
- Class II - Short-acting Beta1 blocker
Adverse Drug Rxns
- Hypotension
- Bronchospasm
Kinetics
Onset of action = 1-4min Duration of action = <30min
Labetalol
Adult Dosing
- Bolus dosing
- 20mg IV followed by 40-80mg q10min up to total of 300mg
- Infusion dosing
- 0.5-2mg/min
Indications
- HTN in setting of myocardial ischemia
- HTN in setting of neurologic injury
- HTN in setting of preeclampsia/eclampsia
Mechanism of Action
- Class II - Nonselective beta blocker
- Alpha1 blocker
Adverse Drug Rxns
- Orthostatic hypotension
Kinetics
- Onset of action = 2-5min (IV)
- Duration of action = 2-4hr (IV)
Sotalol
Adult Dosing
- 80mg PO BID
Indications
- Suppression of ventricular arrhythmias refractory to other meds
- Suppression of SVT, a-fib
Mechanism of Action
- Class II - Nonselective beta-blocker
- Class III effects (prolongs repol and refractoriness)
Adverse Drug Rxns
- Hypotension, bradycardia
- Proarrhythmia (esp in pts w/ hypokalemia)
Kinetics
- Onset of action = 2-3hr
- Duration of action = 24hr
Amiodarone
Adult Dosing
- V-fib/pulseless V-tach
- Loading dose = 300mg IV bolus followed by 150mg bolus prn
- Stable V-tach or SVT
- Loading dose = 150mg IV in 100mL D5W over 10min
- Follow by infusion of 1mg/min x 6hr; 0.5mg/min thereafter
- Loading dose = 150mg IV in 100mL D5W over 10min
Contraindications
Iodine or shellfish allergy
Indications
- Ventricular and supraventricular arrhythmias
- 1st line for pulseless V-tach/V-fib
- Used for atrial arrhythmias in pts w/ decr EF
Mechanism of Action
- Class III - Inhibits potassium channels
- Impairs SA and AV node conduction
- Decreases automaticity
- Prolongs refractory period in accessory pathways
- Also has class I & II properties
Adverse Drug Rxns
- Bradycardia, hypotension
Ibutilide
Adult Dosing
- Loading dose = 1mg IV in 50mL D5W over 10min (wt>60kg)
- Loading dose = 0.01mg/kg IV in 50mL D5W over 10min (wt<60kg)
- Dose may be repeated 10min after completion of 1st dose
Contraindications
Indications
- Rapid conversion of recent-onset A-fib/flutter to NSR
Mechanism of Action
- Class III - Prolongs AP and refractory period
Adverse Drug Rxns
- QT prolongation, V-tach, torsades
- Observe for 4hr after infusion
Kinetics
- Onset of action = 20-30min
- Duration of action = 24hr
Diltiazem
Adult Dosing
- Loading dose = 0.25mg/kg (max=20mg) IV bolus over 2min
- If ineffective after 15min: 0.35mg/g (max=25mg) over 2min
- If effective: Start infusion at 5-15mg/hr
Contraindications
- Wide-complex tachycardia due to bypass tract
Indications
- Conversion of PSVT to NSR
- Slow RVR in a-fib/flutter
Mechanism of Action
- Class IV - Inhibits Ca influx
- Slows AV nodal conduction
Adverse Drug Rxns
Bradycardia, CHF, AV block, BBB, hypotension
Kinetics
- Onset of action = 2-3min (IV)
- Duration of action = 1-3hr (IV)
Atropine
Adult Dosing
- Loading dose = 0.5mg rapid IV bolus q3-5min (max = 0.04 milligram/kg)
- May be given IM, IO, SC
Indications
- Symptomatic sinus or AV nodal bradycardia
Mechanism of Action
- Parasympatholytic
- Increases sinus/AV conduction
Adverse Drug Rxns
- Increased O2 consumption
- If given slowly (or <0.5mg) may lead to paradoxical bradycardia
Kinetics
- Onset of action = 2-4min
- Duration of action = 5hr
Adenosine
Adult Dosing
- 6mg rapid IV bolus over 1-2s
- If ineffective can try 12mg 2min later
- If still ineffective can try another 12mg
- If ineffective can try 12mg 2min later
Contraindications
- 2nd, 3rd AV block
- Sick sinus syndrome
- Reentrant SVTs not involving AV node are not terminated
- No effect on anterograde WPW
Indications
- Conversion of reentrant PSVT to NSR
Mechanism of Action
- Negative inotropic, dromotropic, chronotropic effects
- Transient AV nodal block
Adverse Drug Rxns
- Bronchoconstriction (responds to bronchodilators)
- Bradyarrhythmia
- Hypotension (if given too slowly)
Kinetics
Onset of action = 20-30s Duration of action = 60-90s
Digoxin
Adult Dosing
- Loading dose = 0.25 mg IV q2hr until effect (max total = 1.5 mg
Contraindications
- WPW
- Increases conduction velocity in atrial tissue
Indications
- RVR control in a-fib/flutter, PSVT
Mechanism of Action
- Inhibits NaK pump
- Positive inotropy
- Negative chronotropy/dromotropy
- Indirect vagal stimulator
Adverse Drug Rxns
- GI - N/V, diarrhea, abd pain
- CV - Bradycardia, SA/AV block, ventr arrhythmias
Kinetics
Onset of action = 1.5-4hr (IV)
Isoproterenol
Adult Dosing
2-10mcg/min IV by continuous infusion
Indications
- Refractory torsades
- Refractory symptomatic bradycardia
Mechanism of Action
- Beta agonist
Adverse Drug Rxns
- Dramatic increase in O2 demand
- V-tach (use lowest dose possible)
Kinetics
- Onset of action = 1-5min
- Duration of action = 1-2hr
Magnesium
Adult Dosing
- Loading dose = 1-2gm in 10mL D5W over 1-2min (cardiac arrest)
- Loading dose = 1-4gm in 50-100 D5W over 20-60min (spontaneous circulation)
Contraindications
Indications
Mechanism of Action
- Increases vasomotor tone
- Prolongs AV conduction; prolongs refractoriness
Adverse Drug Rxns
- Hypotension
Kinetics
- Onset of action = Immediate
Source
Tintinalli
